Do Weight Loss Injections Cause Hair Loss?

The biggest misconception: the injection is dissolving your hair

When people search "do weight loss injections cause hair loss", the fear is often that the medicine is somehow toxic to hair. That picture is not what the evidence shows. Neither tirzepatide (Mounjaro) nor semaglutide (Wegovy) has a known direct mechanism that damages hair follicles. What clinical trials did record (including in the SURMOUNT-1 programme and the STEP 1 study) is that a small proportion of participants reported hair loss as a side effect. The NHS medicines page for tirzepatide lists hair loss among less common side effects, defined there as affecting fewer than one in ten people.

The more accurate framing is this: fast weight loss is itself a physical stressor, and the body can respond by pushing more hairs into a resting, shedding phase. The medicine accelerates weight loss; rapid weight loss is the proximate trigger. That distinction matters because the solution is different depending on the cause.

Telogen effluvium typically appears two to four months after the triggering event, so if you started treatment in January and notice a shed in spring, the timeline lines up. Shedding usually peaks and then eases as body weight stabilises. It can feel alarming, especially when you see it on a brush or in the shower, but it is not the same as permanent follicle damage.

Why calorie restriction matters more than people expect

GLP-1 medicines reduce appetite significantly. That is their mechanism. But a sharply reduced appetite, without careful attention to what you are eating, can mean inadequate protein, iron, zinc or biotin, all nutrients the hair growth cycle depends on. When the body is in a calorie deficit, it prioritises essential functions, and hair growth sits low on that list.

This is one reason the licensed guidance for both Mounjaro and Wegovy emphasises a reduced-calorie diet alongside treatment, not a near-zero one. Our prescribers regularly discuss protein targets during consultations, not because the medicine demands it, but because protecting lean mass (and hair) requires deliberate food choices when appetite is suppressed. You can read more about muscle loss risk during weight loss injection treatment for related nutritional context.

If you are losing more than around 500–800 kcal per day below your maintenance needs, or skipping meals because the appetite suppression is so strong, that is worth raising with your prescriber or a dietitian. It is a common pattern, and it is manageable.

When hair loss needs a proper medical look

Not every shed during treatment is telogen effluvium. Thyroid dysfunction (both underactive and overactive thyroid) causes hair loss, and thyroid disease can be present without obvious symptoms. Polycystic ovary syndrome, anaemia and certain autoimmune conditions do the same. If your hair is thinning in patches, at the hairline, or in a pattern rather than an even all-over shed, that is a different clinical picture and warrants investigation beyond a chat about diet.

Tell your prescriber if the shedding is heavy, ongoing after six months, or accompanied by other changes, fatigue, temperature sensitivity, skin or nail changes. Blood tests to check thyroid function, ferritin and full blood count are straightforward and can clarify what is going on. Any unexplained or disproportionate side effect during GLP-1 treatment can also be reported via the MHRA Yellow Card scheme, which helps regulators monitor real-world patterns across many patients.

Separately, if you are unsure whether a prescribed dose change or a new supplement might interact with your treatment, that is a question for your prescriber, not a forum. Our clinical team at nume reviews each case individually; the FAQs page also covers common mid-treatment questions.

What usually happens over time

For most people, hair shedding linked to weight loss slows and stops once the rate of weight change moderates and nutritional intake stabilises. That often coincides with reaching a maintenance dose and moving into a steadier phase of treatment. Regrowth is gradual (hair cycles are long) but it does happen in the majority of cases where telogen effluvium was the cause.

Some people find the shed peaks around month three or four and is largely over by month six. Others notice it later, particularly if weight loss continues at pace through a higher dose. There is no single timeline. If you are mid-treatment and worried, the honest message is: monitor it, eat enough protein, check your bloods, and raise it at your next clinical review rather than stopping treatment abruptly, which can itself cause further fluctuation.

If you are thinking about starting treatment and hair health is a concern, discussing it during your consultation is the right moment, before your first pen arrives, not after. Our prescribers cover side effects as part of every assessment, including questions around whether weight loss injections make you lose hair and what the evidence actually shows. You can also explore the weight loss injections overview for a broader picture of what treatment involves, or look at how a single injection works in practice. For people weighing up their options, it is also worth reading about which injection tends to produce the fastest results, since the pace of weight loss is directly relevant to the hair shedding risk discussed throughout this page. For more detail specific to this topic, our dedicated hair loss and weight loss injections page goes deeper into the mechanism and the evidence.